TP
ABBV icon

Tranquility Partners’s AbbVie ABBV Stock Holding History

Tranquility Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.59M Buy
6,308
+38
+0.6% +$8.18K 0.55% 48
2026
Q1 		$1.36M Sell
6,270
-155
-2% -$34.4K 0.51% 52
2025
Q4 		$1.47M Hold
6,425
– – 0.53% 48
2025
Q3 		$1.49M Buy
6,425
+57
+0.9% +$11.6K 0.5% 51
2025
Q2 		$1.18M Sell
6,368
-208
-3% -$38.7K 0.42% 68
2025
Q1 		$1.38M Hold
6,576
– – 0.53% 48
2024
Q4 		$1.17M Buy
6,576
+1
+0% +$184 0.44% 63
2024
Q3 		$1.3M Hold
6,575
– – 0.47% 53
2024
Q2 		$1.13M Buy
6,575
+34
+0.5% +$5.63K 0.43% 61
2024
Q1 		$1.19M Sell
6,541
-11
-0.2% -$1.9K 0.46% 56
2023
Q4 		$1.02M Sell
6,552
-100
-2% -$14.6K 0.43% 70
2023
Q3 		$992K Sell
6,652
-200
-3% -$29.4K 0.43% 61
2023
Q2 		$923K Buy
6,852
+20
+0.3% +$2.93K 0.4% 68
2023
Q1 		$1.09M Sell
6,832
-1,175
-15% -$180K 0.52% 51
2022
Q4 		$1.29M Buy
8,007
+800
+11% +$123K 0.66% 42
2022
Q3 		$967K Hold
7,207
– – 0.54% 52
2022
Q2 		$1.1M Buy
7,207
+82
+1% +$12.5K 0.57% 48
2022
Q1 		$1.16M Buy
7,125
+135
+2% +$19.6K 0.54% 50
2021
Q4 		$946K Buy
6,990
+85
+1% +$10K 0.44% 67
2021
Q3 		$745K Buy
6,905
+1,432
+26% +$164K 0.38% 77
2021
Q2 		$616K Sell
5,473
-887
-14% -$99.9K 0.35% 86
2021
Q1 		$688K Sell
6,360
-30
-0.5% -$3.21K 0.43% 75
2020
Q4 		$685K Hold
6,390
– – 0.48% 71
2020
Q3 		$560K Sell
6,390
-274
-4% -$25.8K 0.48% 69
2020
Q2 		$654K Buy
6,664
+345
+5% +$30.4K 0.62% 51
2020
Q1 		$481K Buy
6,319
+1,575
+33% +$134K 0.55% 57
2019
Q4 		$420K Buy
+4,744
New +$394K 0.38% 87

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Tranquility Partners's ABBV Position: Q2 2026 in Review

Tranquility Partners increased its AbbVie (ABBV) stake by 0.61% in Q2 2026, buying an estimated $8.18K and bringing the position to 6,308 shares worth $1.59M. The position accounts for 0.55% of the portfolio, ranked #48.

Tranquility Partners first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Tranquility Partners held 6,308 shares of AbbVie worth $1.59M as of Q2 2026.
  • Tranquility Partners bought 38 AbbVie shares in Q2 2026, an estimated $8.18K.
  • AbbVie made up 0.55% of Tranquility Partners's portfolio in Q2 2026, its #48 holding.
  • Tranquility Partners first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Tranquility Partners's 13F filing for Q2 2026, filed 23 Jul 2026.